{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:01:24Z","timestamp":1792796484265,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00259-025-07412-x","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T23:10:40Z","timestamp":1750720240000},"page":"306-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Machine learning-based construction and validation of an radiomics model for predicting ISUP grading in prostate cancer: a multicenter radiomics study based on [68Ga]Ga-PSMA PET\/CT"],"prefix":"10.1007","volume":"53","author":[{"given":"Honghu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7773-2064","authenticated-orcid":false,"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"2","key":"7412_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"key":"7412_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fsurg.2020.00007","volume":"7","author":"M Wenzel","year":"2020","unstructured":"Wenzel M, et al. Complication rates after TRUS guided transrectal systematic and MRI-Targeted prostate biopsies in a High-Risk region for antibiotic resistances. Front Surg. 2020;7:7.","journal-title":"Front Surg"},{"issue":"2","key":"7412_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362.","journal-title":"Eur Urol"},{"issue":"10","key":"7412_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, et al. MRI-Targeted, systematic, and combined biopsy for prostate Cancer diagnosis. N Engl J Med. 2020;382(10):917\u201328.","journal-title":"N Engl J Med"},{"issue":"10","key":"7412_CR5","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00259-021-05261-y","volume":"48","author":"DA Ferraro","year":"2021","unstructured":"Ferraro DA, et al. Diagnostic performance of (68)Ga-PSMA-11 PET\/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study. Eur J Nucl Med Mol Imaging. 2021;48(10):3315\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7412_CR6","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","volume":"195","author":"T Maurer","year":"2016","unstructured":"Maurer T, et al. Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate Cancer. J Urol. 2016;195(5):1436\u201343.","journal-title":"J Urol"},{"issue":"5","key":"7412_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.euf.2016.11.002","volume":"4","author":"FE von Eyben","year":"2018","unstructured":"von Eyben FE, et al. (68)Ga-Labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: A systematic review and Meta-analysis. Eur Urol Focus. 2018;4(5):686\u201393.","journal-title":"Eur Urol Focus"},{"issue":"8","key":"7412_CR8","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00259-019-04620-0","volume":"47","author":"P Donato","year":"2020","unstructured":"Donato P, et al. (68)Ga-PSMA PET\/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: is (68)Ga-PSMA PET\/CT guided biopsy the future? Eur J Nucl Med Mol Imaging. 2020;47(8):1843\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7412_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.juro.2018.01.079","volume":"200","author":"E Lopci","year":"2018","unstructured":"Lopci E, et al. (68)Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate Cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: A prospective observational study. J Urol. 2018;200(1):95\u2013103.","journal-title":"J Urol"},{"issue":"10231","key":"7412_CR10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208\u201316.","journal-title":"Lancet"},{"issue":"8","key":"7412_CR11","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1007\/s00259-023-06187-3","volume":"50","author":"S Ghezzo","year":"2023","unstructured":"Ghezzo S, et al. Role of [(68)Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(8):2548\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"7412_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.prnil.2020.07.008","volume":"9","author":"TN Kwan","year":"2021","unstructured":"Kwan TN, et al. Performance of Ga-68 PSMA PET\/CT for diagnosis and grading of local prostate cancer. Prostate Int. 2021;9(2):107\u201312.","journal-title":"Prostate Int"},{"issue":"5","key":"7412_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, et al. PSMA PET\/CT: joint EANM procedure guideline\/snmmi procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50(5):1466\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"7412_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/pros.24716","volume":"84","author":"JG Heetman","year":"2024","unstructured":"Heetman JG, et al. The additional value of (68)Ga-PSMA PET\/CT SUVmax in predicting ISUP GG\u2009\u2265\u20092 and ISUP GG\u2009\u2265\u20093 prostate cancer in biopsy. Prostate. 2024;84(11):1025\u201332.","journal-title":"Prostate"},{"issue":"3","key":"7412_CR15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.21873\/invivo.13211","volume":"37","author":"P Pepe","year":"2023","unstructured":"Pepe P, et al. (68)Ga-PSMA PET\/CT and prostate Cancer diagnosis: which SUVmax value?? Vivo. 2023;37(3):1318\u201322.","journal-title":"Vivo"},{"issue":"6","key":"7412_CR16","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1002\/cam4.5516","volume":"12","author":"N Yi","year":"2023","unstructured":"Yi N, et al. Ability of (68) Ga-PSMA PET\/CT SUVmax to differentiate ISUP GG2 from GG3 in intermediate-risk prostate cancer: A single-center retrospective study of 147 patients. Cancer Med. 2023;12(6):7140\u20138.","journal-title":"Cancer Med"},{"key":"7412_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fonc.2018.00630","volume":"8","author":"A Chaddad","year":"2018","unstructured":"Chaddad A, et al. Predicting Gleason score of prostate Cancer patients using radiomic analysis. Front Oncol. 2018;8:630.","journal-title":"Front Oncol"},{"issue":"1","key":"7412_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.18383\/j.tom.2018.00033","volume":"5","author":"SD McGarry","year":"2019","unstructured":"McGarry SD, et al. Gleason probability maps: A radiomics tool for mapping prostate Cancer likelihood in MRI space. Tomography. 2019;5(1):127\u201334.","journal-title":"Tomography"},{"issue":"7","key":"7412_CR19","doi-asserted-by":"publisher","first-page":"e0217702","DOI":"10.1371\/journal.pone.0217702","volume":"14","author":"J Toivonen","year":"2019","unstructured":"Toivonen J, et al. Radiomics and machine learning of multisequence multiparametric prostate MRI: towards improved non-invasive prostate cancer characterization. PLoS ONE. 2019;14(7):e0217702.","journal-title":"PLoS ONE"},{"issue":"3","key":"7412_CR20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/JU.0000000000000272","volume":"202","author":"SJ Hectors","year":"2019","unstructured":"Hectors SJ, et al. Radiomics features measured with multiparametric magnetic resonance imaging predict prostate Cancer aggressiveness. J Urol. 2019;202(3):498\u2013505.","journal-title":"J Urol"},{"issue":"6","key":"7412_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","volume":"70","author":"M Perera","year":"2016","unstructured":"Perera M, et al. Sensitivity, specificity, and predictors of positive (68)Ga-Prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: A systematic review and Meta-analysis. Eur Urol. 2016;70(6):926\u201337.","journal-title":"Eur Urol"},{"issue":"2","key":"7412_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00259-021-05430-z","volume":"49","author":"EL Solari","year":"2022","unstructured":"Solari EL, et al. The added value of PSMA PET\/MR radiomics for prostate cancer staging. Eur J Nucl Med Mol Imaging. 2022;49(2):527\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"7412_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12149-021-01705-5","volume":"36","author":"A Aksu","year":"2022","unstructured":"Aksu A, et al. Dual time point imaging of staging PSMA PET\/CT quantification; spread and radiomic analyses. Ann Nucl Med. 2022;36(3):310\u20138.","journal-title":"Ann Nucl Med"},{"issue":"9","key":"7412_CR24","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.7150\/thno.32376","volume":"9","author":"C Zamboglou","year":"2019","unstructured":"Zamboglou C, et al. Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference. Theranostics. 2019;9(9):2595\u2013605.","journal-title":"Theranostics"},{"issue":"6","key":"7412_CR25","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00259-020-05140-y","volume":"48","author":"L Papp","year":"2021","unstructured":"Papp L, et al. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [(68)Ga]Ga-PSMA-11 PET\/MRI. Eur J Nucl Med Mol Imaging. 2021;48(6):1795\u2013805.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07412-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07412-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07412-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:05:40Z","timestamp":1764219940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07412-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7412"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07412-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was ethically approved by the Ethics Review Committee of Xiangya Hospital, Central South University (Changsha, PR, China). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}